Constipation can be defined as a condition with decreased stool frequency or issues in passing stool. Reduced or tough stool passage is accompanied by hard lumpy stools, incomplete bowel actions, straining, incomplete evacuation, and necessity for manual elimination of stool. Chronic idiopathic constipation (CIC) can be described as an additional, persistent or extreme continuation of the above-mentioned signs and symptoms. Several times, the cause of chronic idiopathic constipation is not known. Since the cause of constipation is uncertain, it is known as idiopathic constipation. Chronic idiopathic constipation Market is often indicated with more than one symptoms.
Based on drug class, the global chronic idiopathic constipation market can be segmented into emollients, laxatives, chloride channel activators, osmotic products, and others. The laxatives segment is likely to expand at a significant pace during the forecast period. The advantage of a laxative is that it can be generally sold over the counter and it can even be prescribed as the first line of treatment to relieve idiopathic constipation. Based on route of administration, the chronic idiopathic constipation market can be segmented into oral and parenteral. The oral segment is likely to expand at a rapid pace during the forecast period, as patients prefer taking oral drugs as they are convenient, invasive, and require no special training to take drugs. Based on distribution mode, the chronic idiopathic constipation market can be segmented into prescription drugs and over-the-counter drugs. The prescription drugs segment is likely to expand at a significant pace during the forecast period, as patients prefer taking drugs prescribed by the doctor to avoid any possible side-effects. In terms of distribution channel, the chronic idiopathic constipation market can be segmented into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period, as patients prefer hospital pharmacies to buy drugs due to availability of a variety of drugs to treat CIC in these pharmacies. Additionally, patients have easy access to several medicines prescribed by the doctor. Increasing prevalence of irritable bowel syndrome with constipation (IBS-C), rising use of opioid drugs, and growing geriatric population across the region are factors driving the global chronic idiopathic constipation market. However, low awareness about guidelines for the diagnosis and treatment of idiopathic constipation are likely to hamper chronic idiopathic constipation market in the next few years.
In terms of region, the global chronic idiopathic constipation market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global chronic idiopathic constipation market. The region is projected to hold a significant share of the global chronic idiopathic constipation market during the forecast period, due to increasing prevalence of chronic idiopathic constipation among the geriatric population in the region. Shifting focus of key players in Europe toward specialty constipation medicines is likely to drive of the demand for specialty therapeutic options such as PAMORA’s and GC-C agonists in the region. On the other hand, high prevalence of functional constipation and increasing health care expenditure in Asia Pacific are expected to fuel the chronic idiopathic constipation market in the region during the forecast period. Advancements in drug delivery, increase in per capita income, and availability of generic drugs are likely to augment the chronic idiopathic constipation Market in Middle East & Africa during the forecast period.
Key players operating in the global chronic idiopathic constipation market are GlaxoSmithKline Plc., Bayer AG, Allergan Plc., Ironwood Pharmaceuticals, Inc., Astellas Pharma, Inc., Synergy Pharmaceuticals, Inc., Sanofi S.A., and Pfizer, Inc. among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.